Using Thromboelastography to Predict Blood Clotting Problems After Traumatic Brain Injury and Their Impact on Patient Outcomes

What this Trial Is About

Researchers are investigating how hemocoagulation disorders affect patients with traumatic brain injury TBI. This study focuses on the use of thromboelastography, a test to evaluate blood clotting, to determine whether posttraumatic coagulation problems lead to additional damage after head trauma and how these issues influence patient outcomes. The goal is to develop and validate prediction models or risk scores to better foresee coagulation-related complications following TBI. The study includes patients who arrive at the hospital within 24 hours of head trauma and have isolated traumatic brain injury, defined by specific injury scoring criteria for other body regions. Researchers will observe and analyze these patients without administering experimental treatments, focusing on natural progression and outcomes related to coagulation status. Participants will be monitored for their clinical outcomes using tools such as the Glasgow Outcome Scale at six months after injury. Data collection will likely involve thromboelastography and other clinical assessments to evaluate coagulation-related damage. The study spans from 2018 to 2027, allowing long-term observation of patient recovery and complications related to blood clotting after TBI.

The Utility of Thromboelastography in Traumatic Brain Injury